BioMarin Pharmaceutical provides therapeutics for mucopolysaccaradosis type I (MPS I), by manufacturing laronidase (Aldurazyme), commercialized by Genzyme.
pharmaceutical industry | Pharmaceutical industry | Pharmaceutical drug | pharmaceutical drug | Royal Pharmaceutical Society of Great Britain | Royal Pharmaceutical Society | Pharmaceutical Product Development | Kyoto Pharmaceutical University | International Society for Pharmaceutical Engineering | University of Veterinary and Pharmaceutical Sciences, Brno | University of Copenhagen Faculty of Pharmaceutical Sciences | Pharmaceutical formulation | Hisamitsu Pharmaceutical | BioMarin Pharmaceutical | Association of the British Pharmaceutical Industry |